Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services entities : Century therapeutics inc save search
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 3.39%
H: 11.53%
C: 2.02%
disease million pipeline acquisition expansion therapeutics
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-08 (Crawled : 20:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -1.59%
H: 8.87%
C: 7.8%
association cancer cell research preclinical for meeting technology therapeutics therapy platform
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
SGMT | $4.55 -5.8% -6.15% 470K
|
Health Technology
|
| O: 6.65%
H: 18.5%
C: 8.52%
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.58%
C: -9.48%
RPHM | $1.67 -3.47% -3.59% 190K
|
Professional, Scientific, and T...
|
| O: -1.81%
H: 4.91%
C: 2.45%
XOMA | $24.74 -4.29% -4.49% 6.1K
|
Health Technology
|
| O: 1.09%
H: 3.51%
C: -4.27%
MIRM | $23.95 -2.56% -2.63% 400K
|
Health Technology
|
| O: 0.0%
H: 1.61%
C: 0.04%
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 1.26%
H: 1.25%
C: -0.21%
conference cell therapeutics therapy
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -0.41%
H: 0.0%
C: -6.82%
business year therapeutics financial results
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 23:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 2.59%
H: 16.28%
C: 14.68%
six association cancer research meeting therapeutics
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Published: 2024-02-01 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -1.4%
H: 10.9%
C: 0.24%
conference therapeutics
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
Published: 2023-12-09 (Crawled : 20:20) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
cnty-101 trial therapeutics potential
Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus
Published: 2023-12-06 (Crawled : 12:30) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 8.23%
H: 33.92%
C: 25.73%
cnty-101 conference lupus lymphomas trial therapeutics study
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
Published: 2023-12-06 (Crawled : 12:30) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 8.23%
H: 33.92%
C: 25.73%
cnty-101 fda lupus clearance application therapeutics
Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
Published: 2023-11-21 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 0.7%
H: 1.18%
C: -3.47%
conference therapeutics
Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -5.0%
H: 10.53%
C: -8.55%
business therapeutics financial results
Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -5.0%
H: 10.53%
C: -8.55%
cell commercialization therapeutics
Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -5.0%
H: 10.53%
C: -8.55%
therapeutics
Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and Exposition
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 4.03%
H: 6.45%
C: -1.29%
meeting therapeutics potential
Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference
Published: 2023-09-26 (Crawled : 11:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: 0.48%
H: 2.37%
C: -3.79%
conference genetic therapeutics
Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
Published: 2023-08-09 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -1.03%
H: 0.7%
C: -0.7%
business therapeutics financial results
Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -0.58%
H: 2.93%
C: -1.17%
business therapeutics financial results
Century Therapeutics Announces Leadership Changes
Published: 2023-04-12 (Crawled : 13:20) - biospace.com/
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -1.58%
H: 2.89%
C: -6.43%
therapeutics
Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates
Published: 2023-03-16 (Crawled : 12:00) - globenewswire.com
IPSC | $3.675 -6.01% -6.39% 42K
|
Professional, Scientific, and T...
|
| O: -0.74%
H: 4.25%
C: -0.5%
business year therapeutics financial results
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.